English

Share Buyback in H. Lundbeck A/S

Report this content 

                        
Acting on its authorization to acquire up to 10% of its shares the H.
Lundbeck Supervisory Board has resolved to initiate a share buyback
program. Under the program H. Lundbeck will buy own shares for an
amount of up to DKK 6 billion, cf. stock exchange announcement number
166 on 17th August 2005.

During any one single trading day a maximum of 25% of the average
daily trading volume of Lundbeck shares on the Copenhagen Stock
Exchange, calculated over 20 days prior to each trading date, will be
bought back, as the share buyback program is implemented in
accordance with the provisions of the European Commission's
regulation no. 2273/2003 of December 22, 2003.

At least once every seven trading days, Lundbeck will issue an
announcement in respect of the transactions made under the program.

The following transactions have been made under the program:


                       No. of shares        Average Transaction value
                                     purchase price             (DKK)
                                              (DKK)
Accumulated, last         22,890,447       134.7238     3,083,888,086
announcement
04 September 2007             28,925       132.6401      3,836,615.77
05 September 2007             76,829       135.0677     10,377,117.21
06 September 2007                 --             --                --
07 September 2007                 --             --                --
10 September 2007             32,326       134.4838      4,347,321.84
11 September 2007                 --             --                --
12 September 2007                 --             --                --
Accumulated under the     23,028,527       134.7220     3,102,449,141
program




Following the above buyback it is hereby announced that Lundbeck owns
a total of 3,871,740 own shares at a nominal value of DKK 5, equal to
1.87% of the total number of 207,279,631 shares.

The content of this release will have no influence on the Lundbeck
Group's financial result for 2007.

Lundbeck contacts


Investors:                   Media:

Jacob Tolstrup               Caroline Broge
Director, Investor Relations Media Relations Manager
+45 36 43 30 79              +45 36 43 26 38
+1 201 350 0187


                      ________________________

Stock Exchange Release No 293 - 12 September 2007

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com




                                            

                

            

        

    

    



    

        
 Subscribe

        

            

        

    


        

            
        

        

            
        

        



    

        
 Documents & Links